Paying users zone. Data is hidden behind 
.
Get 1-month access to Regeneron Pharmaceuticals Inc. for $15.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)
Statement of Comprehensive Income
Beginner level
Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Regeneron Pharmaceuticals Inc., consolidated statement of comprehensive income
US$ in thousands
Based on: 10-K (filing date: 2020-02-07), 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11).
| Comprehensive income item | Description | The company |
|---|---|---|
| Net income | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Regeneron Pharmaceuticals Inc.’s net income increased from 2017 to 2018 but then slightly decreased from 2018 to 2019. |
| Comprehensive income | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. | Regeneron Pharmaceuticals Inc.’s comprehensive income increased from 2017 to 2018 but then slightly decreased from 2018 to 2019. |